Active Ingredient: POLYMYXIN B SULFATE
Proprietary Name: POLYMYXIN B SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500,000 UNITS BASE/VIAL
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AP
Application Number: A202766
Product Number: 001
Approval Date: Jan 15, 2014
Applicant Holder Full Name: XELLIA PHARMACEUTICALS APS
Marketing Status:
Prescription
Patent and Exclusivity Information